Dow AgroSciences Divests European Dithane Business to Indofil Industries Ltd.
Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), has divested its European Dithane® fungicide business to Indofil Industries Ltd. of Mumbai, India.
The agreement includes only Dithane® products sold in Europe and does not include other parts of the Dow AgroSciences’ Dithane business.
Indofil, part of India’s K.K. Modi Group, has purchased the rights and associated trademarks of Dithane® only in Europe, exclusive rights to use the patented NT technology and related trademarks in Europe, Dithane® registrations and data to support these, and the customer contracts which can be assigned.
“Dow AgroSciences remains committed to the Dithane® business in other parts of the world where we have production assets and are better able to compete over time,” says David Hindes, Global Fungicide Business Leader. “This divestment will allow us to focus our European investment on new novel chemistries in the future.”
“This is an exciting time for Indofil Industries in Europe, consolidating Indofil’s position in the European mancozeb market segment and making it a leading player,” says K.K. Modi, Group Chairman, K.K. Modi Group.
Indofil was the manufacturer and distributor of Dithane® in India for 40 years under Rohm and Haas. “Indofil is excited to welcome the Dithane product back in its portfolio, and is committed to growing the Dithane® market across Europe, through active collaboration with all partners,” says R.K. Malhotra, CEO, Indofil Industries Limited.
The companies are working together to ensure a seamless transition and minimal impact to customers, distributors, and dealers.
Financial terms of the agreement were not disclosed.
About Dow AgroSciences
Dow AgroSciences, based in
Indianapolis, Indiana, USA, develops leading-edge crop protection and
plant biotechnology solutions to meet the challenges of the growing
world. Dow AgroSciences is a wholly owned subsidiary of The Dow Chemical
Company and had annual global sales of $5.7 billion in 2011. Learn more
at www.dowagro.com
.
Follow Dow AgroSciences on Facebook
and
YouTube
or
subscribe to our News
Release RSS Feed
.
About Indofil Industries Limited
Indofil Industries Limited,
established more than four decades ago, headquartered in Mumbai, is a
research-led, fully integrated agri-business company. Since 2007,
Indofil has grown at an annual rate of 27%. With a state-of-the-art
manufacturing set-up, an experienced R&D team, and a strong domestic and
international distribution network, Indofil manufactures and sells crop
protection products and specialty chemicals products across the globe.
Indofil was the manufacturer and distributor of Dithane in India, for 40
years, under Rohm and Haas. Today, it leads the Indian Mancozeb market
and exports Mancozeb formulations to more than 50 countries. Indofil was
recognized as the “Best Company from an Emerging Region” at the AGROW
awards, London, in 2010.
For more information visit: www.indofilcc.com
Contact:
Dow AgroSciences
Robyn Heine, 317-337-4807
rheine@dow.com
or
Indofil
Industries Limited
Shekhar Shetty, +91 22 66637403
sdshetty-icc@modi.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 09:15:00 CEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 09:00:00 CEST | Press release
Show Reconvenes at Paris Expo Porte de Versailles with Global Representation of Industry Leaders and Telco Experts Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 09:00:00 CEST | Press release
New Collection Features an Evolution in Design that Cuts Through the Wind for That Aerodynamic Feel on Every Run Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vic
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom